Home/Filings/4/0001209191-08-001004
4//SEC Filing

Adams Respiratory Therapeutics, Inc. 4

Accession 0001209191-08-001004

CIK 0001319439operating

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:01 PM ET

Size

20.3 KB

Accession

0001209191-08-001004

Insider Transaction Report

Form 4
Period: 2008-01-02
Valentino Michael J
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2008-01-02$0.40/sh+70,000$28,00070,000 total
  • Sale

    Common Stock

    2008-01-02$59.64/sh12,300$733,57257,700 total
  • Sale

    Common Stock

    2008-01-02$59.68/sh4,800$286,4641,432 total
  • Sale

    Common Stock

    2008-01-02$59.67/sh8,012$478,0766,232 total
  • Sale

    Common Stock

    2008-01-02$59.71/sh32$1,9110 total
  • Sale

    Common Stock

    2008-01-02$59.66/sh10,081$601,43214,244 total
  • Sale

    Common Stock

    2008-01-02$59.65/sh33,375$1,990,81924,325 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2008-01-0270,000512,745 total
    Exercise: $0.40Exp: 2013-08-11Common Stock (70,000 underlying)
  • Sale

    Common Stock

    2008-01-02$59.69/sh700$41,783732 total
Footnotes (2)
  • [F1]The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2006.
  • [F2]20% of the options vested on August 11, 2003, and the remainder of the options vest in prorata monthly installments over four years.

Issuer

Adams Respiratory Therapeutics, Inc.

CIK 0001319439

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001319439

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:01 PM ET
Size
20.3 KB